Tag: Safety

Changes in hospital-acquired conditions, mortality after HACRP

Editor's Note In this study, researchers from the University of Michigan, Ann Arbor, find that hospital-acquired conditions (HACs) targeted by the Centers for Medicare and Medicaid Services (CMS) Hospital-Acquired Condition Reduction Program (HACRP) declined after the program was announced, but 30-day mortality was unchanged. The analysis included 8,857,877 Medicare beneficiaries…

Read More

By: Judy Mathias
October 6, 2021
Share

Study: HCW shortages expected for every state by 2026

Editor's Note Mercer’s 2021 External Healthcare Labor Market Analysis finds a shortage of healthcare workers (HCWs) over the next 5 to 10 years as the US continues to deal with the COVID-19 pandemic. The main findings of the study are: There will be a labor shortage at the low end…

Read More

By: Judy Mathias
October 6, 2021
Share

Association of physical activity, screen time with children’s mental health during COVID-19

Editor's Note This study from the Seattle Children’s Research Institute and University of Washington finds that more physical activity and less screen time were associated with better mental health for children during the COVID-19 pandemic. A survey was conducted from October 22 to November 2, 2020, of 547 parents of…

Read More

By: Judy Mathias
October 5, 2021
Share

FDA: Class I recall of Amsorb Plus used to absorb carbon dioxide in anesthesia machines

Editor's Note The Food and Drug Administration (FDA), on September 23, identified the recall by Armstrong Medical of certain lots of its Amsorb Plus Prefilled G-Can 1.0L canisters as Class I, the most serious. Amsorb Plus is a chemical substance used in anesthesia machines to absorb carbon dioxide the patient…

Read More

By: Judy Mathias
October 5, 2021
Share

Occupational exposures, secondary cases of COVID-19 in HCWs

Editor's Note In this study, researchers from Northwestern Memorial Hospital and Feinberg School of Medicine, Chicago, find that more healthcare workers (HCWs) were exposed to COVID-19 by coworkers than patients, and lapses in infection prevention practices increased transmission risk. Between June and December 2020, 2,357 HCWs were involved in occupational…

Read More

By: Judy Mathias
October 4, 2021
Share

The Joint Commission posts new sentinel event data

Editor's Note The Joint Commission, on September 29, released new sentinel event data for the first 6 months of 2021. The summary data of sentinel event statistics for the first half of 2021 covers 16,695 incidents reported from 1995 through June 30, 2021. Of these sentinel events: 47% led to…

Read More

By: Judy Mathias
October 4, 2021
Share

CDC: Safety monitoring of COVID-19 vaccine booster dose

Editor's Note This study by researchers at the Centers for Disease Control and Prevention finds that adverse reactions after the third dose of Pfizer-BioNTech’s COVID-19 vaccine were similar to those after the second dose. Of 12,591 participants who completed a survey after all three doses: 79.4% and 74.1% reported local…

Read More

By: Judy Mathias
October 1, 2021
Share

ECRI partners with FDA on safety of materials in medical devices

Editor's Note ECRI, on September 30, announced a new partnership with the Food and Drug Administration (FDA) to improve the safety of medical devices through the use of safer materials. ECRI is developing safety reports for materials commonly used in implantable medical devices and assessing their possible effects on patients…

Read More

By: Judy Mathias
October 1, 2021
Share

Outdoor daylight exposure, longer sleep promote wellbeing during COVID-19 restrictions

Editor's Note This study by Israeli researchers finds that restrictions implemented during COVID-19 dramatically altered daily routines and limited time spent outdoors, which resulted in deteriorating personal wellbeing. The analysis of 7,517 adults from 40 countries who were surveyed during the 2020 COVID-19 restrictions found that social restrictions impaired all…

Read More

By: Judy Mathias
September 23, 2021
Share

FDA authorizes Pfizer-BioNTech COVID-19 vaccine boosters for certain populations

Editor's Note The Food and Drug Administration (FDA) on September 22 amended the emergency use authorization (EUA) for Pfizer-BioNTech’s COVID-19 vaccine to allow for use of a single booster to be administered at least 6 months after completion of the primary series in those: 65 years of age and older…

Read More

By: Judy Mathias
September 23, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat